Tuesday, November 24, 2020

Tag: Covid-19 Essential Business

Your Week In Brief; 7 Things Investors Should Be Thankful for...

This Thanksgiving, with so many families unable or unwilling (often smartly), to get together during the holiday, such a historically lazy and obvious answer has been suddenly endowed with real meaning.

Your Week In Brief; Escape with these Staycation Stocks over the...

Yes, even after that Pfizer thing. And neither are any of those cruise or airplane stocks. While the week began as the long-awaited rotation out of stay-at-home tech and into the beaten-down travel sector, the rotation already came and went. It lasted a whole day, long enough to sell those cruise stocks on the pop—I did.

Your Week In Brief; Guns, Germs, and Zeal

Health insurer UnitedHealth Group (NYSE: UNH) rose 10%, while Cigna Corp (NYSE: CI) andAnthem Inc (NYSE: ANTM) jumped by double digits. These three stocks are solid buys for broad-sector exposure. But there is no healthcare company more perfectly positioned to benefit for what will be a long, dark winter of germs than Teledoc (NYSE: TDOC).

Defense Technologies International Corp. (DTII) Receives Funding to Retire a Convertible...

Defense Technologies International Corp. (DTII) Receives Funding to Retire a Convertible Note and for Production

Your Week In Brief; These Small Caps Are Betting Big on...

Neuronetics’ flagship product is the NeuroStar Advanced Therapy System. NeuroStar uses transcranial magnetic stimulation (TMS) to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Your Week In Brief; Big Trouble in Little Hollywood

The stock was in the green this week after releasing another denial of fraud allegations levied at the company courtesy of Wolfpack Research back in April. Citing in-person surveys of more than 1,500 people and Chinese credit reports of iQiyi’s VIEs and WFOEs, the short seller claimed that the Chinese entertainment platform overstated its user numbers and inflated its revenues in SEC filings by as much as 261.7% pre-IPO. Further, in 2019, Wolfpack estimated that iQiyi inflated revenue by 27% to 44%. Are they another Luckin Coffee? Maybe. But like Luckin, iQiyi can be both a liar and long-term winner. The SEC launched a probe into iQiyi and its parent company, Baidu (Nasdaq: BIDU).

Your Week In Brief; I’m feeling Luckin

Most of us know the story of Luckin Coffee. In a nutshell, the company was supposed to be the Starbucks of China, giving the American coffee giant a run for its money on the Mainland. The Beijing-based company launched in 2017 and quickly grew its stores and pick-up locations to rival Starbucks (Nasdaq: SBUX) in China. The stock exploded in popularity. And then, it just exploded.

Your Week In Brief; Bet on Political Volatility and Market Stability

Maher was right: Trump would rather set a fuse to our democracy than admit defeat. Even in the unlikely event of a blowout Biden victory, Trump will stay in office until a deep state statesman tosses him out. One thing the conspiracy-obsessed Trump supporters do have right is that thereis indeed a deep state despite Trump’s efforts to replace everyone in the government with sycophants. At least I hope so; we will need them.

Your Week In Brief; In Fraud We Trust

From lying about the state of containment of the coronavirus or the state of labor camps where a million or more ethnic minorities toil to lying about intellectual property theft, China lies and lies big. And so do its companies. But not like they used to. The frauds of the early 2000s were both the biggest and the most colorful.

Your Week in a Brief; I have Debt

The real worry for many economists isn’t the debt on the books, which as discussed isn’t a problem so long as payments are manageable, but the “off-balance sheet liabilities,” which are spending commitments that fall outside of the promise to pay back borrowed money. The bulk of these commitments are Social Security, pension guarantees, Medicare, and Medicaid.